| Authors: |
Szpakowska M; Immuno-Pharmacology and Interactomics, Department of Infection and Immunity, Luxembourg Institute of Health (LIH), Esch-sur-Alzette, Luxembourg., Legler DF; Institute of Cell Biology and Immunology Thurgau (BITG), University of Konstanz, Kreuzlingen, Switzerland.; Faculty of Biology, University of Konstanz, Konstanz, Germany.; Theodor Kocher Institute, University of Bern, Bern, Switzerland., Offermanns S; Department of Pharmacology, Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany.; Cardiopulmonary Institute, Bad Nauheim, Germany.; Center for Molecular Medicine, Goethe University Frankfurt, Frankfurt, Germany.; German Center for Cardiovascular Research, Partner Site Frankfurt, Bad Nauheim, Germany., Sozzani S; Department of Molecular Medicine, Sapienza University of Rome, Laboratory Affiliated to Institute Pasteur-Italia, Rome, Italy., Rot A; Centre for Microvascular Research, William Harvey Research Institute, Queen Mary University of London, London, UK., Thelen M; Institute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland., Chevigné A; Immuno-Pharmacology and Interactomics, Department of Infection and Immunity, Luxembourg Institute of Health (LIH), Esch-sur-Alzette, Luxembourg. andy.chevigne@lih.lu. |
